Sanofi (SNY) Cash from Investing Activities (2009 - 2026)

Sanofi has disclosed Cash from Investing Activities across 8 years of filings, most recently posting -$424.3 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities fell 103.94% year-over-year to -$424.3 million; the TTM figure through Jun 2026 stood at -$6.3 billion (down 422.44% YoY), while the FY2025 annual figure was -$15.0 billion, down 221.52% from the prior year.
• Cash from Investing Activities came in at -$424.3 million for Q2 2026 at Sanofi, up from -$2.7 billion in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $10.8 billion in Q2 2025 to a low of -$6.7 billion in Q4 2023.
• Average Cash from Investing Activities over 5 years is -$1.2 billion, with a median of -$2.1 billion recorded in 2022.
• Year-over-year, Cash from Investing Activities surged 428.48% in 2025 and plunged 226.73% in 2026.
• Over 5 years, Cash from Investing Activities stood at -$2.1 billion in 2022, then plunged by 215.11% to -$6.7 billion in 2023, then grew by 29.4% to -$4.7 billion in 2024, then surged by 39.52% to -$2.8 billion in 2025, then surged by 85.11% to -$424.3 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$424.3 million in Q2 2026, -$2.7 billion in Q1 2026, and -$2.8 billion in Q4 2025.